Related Experiment Video
Updated: Jan 31, 2026

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
Immunotherapy for hepatocellular carcinoma: current status and future perspectives
Takuji Okusaka1, Masafumi Ikeda2
1Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Immune checkpoint inhibitors, like anti-cytotoxic T lymphocyte-associated protein 4 (CTLA-4) and anti-programmed cell death 1 (PD-1) antibodies, are revolutionizing cancer therapy. Their application in hepatocellular carcinoma (HCC) treatment shows significant promise, especially in combination therapies.
Area of Science:
- Oncology
- Immunology
- Cancer Therapeutics
Background:
- Immune checkpoint inhibitors have significantly advanced cancer treatment strategies.
- Therapeutic antibodies targeting CTLA-4, PD-1, and PD-L1 are approved for various cancers.
- Hepatocellular carcinoma (HCC) is a target for ongoing clinical evaluation of these immunotherapies.
Purpose of the Study:
- To review the impact of immune checkpoint inhibitors on cancer treatment.
- To highlight the potential of these inhibitors in managing hepatocellular carcinoma (HCC).
- To explore the synergistic effects of combining immune checkpoint inhibitors with other therapies for HCC.
Main Methods:
- Review of clinical studies and therapeutic approvals.
- Analysis of immune checkpoint inhibitor mechanisms in cancer.
- Evaluation of combination therapy strategies for HCC.
Main Results:
- Immune checkpoint inhibitors have demonstrated efficacy in diverse cancer types.
- Clinical trials are actively investigating their role in HCC treatment.
- Potential synergistic effects with molecular targeted agents and local therapies are observed.
Conclusions:
- The introduction of immune checkpoint inhibitors marks a new era in cancer treatment.
- These inhibitors, particularly for HCC, offer novel therapeutic avenues.
- Combination strategies are expected to enhance treatment outcomes for HCC patients.
Related Concept Videos
Tumor Immunotherapy
Psychodynamic Perspectives on Personality
Psychodynamic theorists argue that unconscious...
Social Cognitive Perspective on Personality
Criticisms of the Evolutionary Perspective
Evolutionary psychology provides one explanation for these findings, suggesting...
The Behavioral Perspective on Personality
Marcia's Theory of Identity Status

